| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.21e-04 | 76 | 202 | 6 | GO:0098631 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD1 ADGRB3 ASAP1 CAVIN4 RIN2 RGPD5 DOCK1 RGPD8 RALGAPB ARFGEF1 ARHGAP5 | 1.34e-04 | 279 | 202 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.03e-04 | 3 | 202 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | RNA uridylyltransferase activity | 3.03e-04 | 3 | 202 | 2 | GO:0050265 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.42e-04 | 14 | 202 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 3.79e-04 | 61 | 202 | 5 | GO:0098632 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PRTG CD2AP ADGRB3 RREB1 LARP4 TNMD BRWD3 ITPR1 DST CLU PTPRZ1 NBEAL2 PCDH15 ALCAM TCTN1 VIL1 CNTN4 FLNA DSCAM APBB2 LAMA3 JMJD1C LRP4 KIAA1755 LGR6 TNR MUC3A CDH9 | 1.09e-05 | 1194 | 198 | 28 | GO:0000902 |
| GeneOntologyCellularComponent | perineuronal net | 1.03e-04 | 10 | 203 | 3 | GO:0072534 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYOM1 PPP1R12A TMOD3 CMYA5 CAVIN4 DST MYL6B FLNA FLNC DCTN4 MYBPC3 | 1.32e-04 | 290 | 203 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.41e-04 | 11 | 203 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | A band | 1.47e-04 | 52 | 203 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | sarcomere | MYOM1 PPP1R12A TMOD3 CMYA5 CAVIN4 DST FLNA FLNC DCTN4 MYBPC3 | 1.69e-04 | 249 | 203 | 10 | GO:0030017 |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.40e-04 | 13 | 203 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | myofibril | MYOM1 PPP1R12A TMOD3 CMYA5 CAVIN4 DST FLNA FLNC DCTN4 MYBPC3 | 3.52e-04 | 273 | 203 | 10 | GO:0030016 |
| GeneOntologyCellularComponent | actin cytoskeleton | ACACA PPP1R12A CD2AP TMOD3 ASAP1 ACTL7A DST MYL6B VCAM1 VIL1 FLNA FLNC FLT1 DCTN4 STK38L | 5.30e-04 | 576 | 203 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 5.56e-04 | 4 | 203 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | sarcoplasm | 8.71e-04 | 114 | 203 | 6 | GO:0016528 | |
| Domain | - | PRTG CEACAM5 MYOM1 VSIG4 CMYA5 PTPRZ1 ALCAM VCAM1 CNTN4 FLNA FLNC FLT1 DSCAM CD22 VCAN CRTAM TNR IL5RA CD96 MYBPC3 | 2.15e-05 | 663 | 195 | 20 | 2.60.40.10 |
| Domain | Ig_I-set | 3.19e-05 | 190 | 195 | 10 | IPR013098 | |
| Domain | I-set | 3.19e-05 | 190 | 195 | 10 | PF07679 | |
| Domain | IGc2 | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 MYBPC3 | 3.79e-05 | 235 | 195 | 11 | SM00408 |
| Domain | Ig_sub2 | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 MYBPC3 | 3.79e-05 | 235 | 195 | 11 | IPR003598 |
| Domain | Ig-like_fold | PRTG CEACAM5 MYOM1 VSIG4 CMYA5 PTPRZ1 ALCAM VCAM1 CNTN4 FLNA FLNC FLT1 DSCAM CD22 VCAN CRTAM TNR IL5RA CD96 MYBPC3 | 5.20e-05 | 706 | 195 | 20 | IPR013783 |
| Domain | FN3_dom | 7.14e-05 | 209 | 195 | 10 | IPR003961 | |
| Domain | VCAM-1 | 1.08e-04 | 2 | 195 | 2 | IPR003989 | |
| Domain | IG | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 VCAN CRTAM CD96 MYBPC3 | 1.42e-04 | 421 | 195 | 14 | SM00409 |
| Domain | Ig_sub | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 VCAN CRTAM CD96 MYBPC3 | 1.42e-04 | 421 | 195 | 14 | IPR003599 |
| Domain | FN3 | 1.45e-04 | 185 | 195 | 9 | SM00060 | |
| Domain | Grip | 1.74e-04 | 11 | 195 | 3 | SM00755 | |
| Domain | GRIP | 1.74e-04 | 11 | 195 | 3 | PF01465 | |
| Domain | ig | 1.77e-04 | 190 | 195 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.77e-04 | 190 | 195 | 9 | IPR013151 | |
| Domain | Ran_BP1 | 2.30e-04 | 12 | 195 | 3 | PF00638 | |
| Domain | RANBD1 | 2.30e-04 | 12 | 195 | 3 | PS50196 | |
| Domain | GRIP_dom | 2.30e-04 | 12 | 195 | 3 | IPR000237 | |
| Domain | GRIP | 2.30e-04 | 12 | 195 | 3 | PS50913 | |
| Domain | FN3 | 2.50e-04 | 199 | 195 | 9 | PS50853 | |
| Domain | Ig_V-set | 2.50e-04 | 199 | 195 | 9 | IPR013106 | |
| Domain | RanBD | 2.97e-04 | 13 | 195 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.97e-04 | 13 | 195 | 3 | IPR000156 | |
| Domain | fn3 | 3.07e-04 | 162 | 195 | 8 | PF00041 | |
| Domain | InsP3_rcpt-bd | 3.23e-04 | 3 | 195 | 2 | IPR000493 | |
| Domain | Fumarylacetoacetase_C-rel | 6.42e-04 | 4 | 195 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 6.42e-04 | 4 | 195 | 2 | PF01557 | |
| Domain | - | 6.42e-04 | 4 | 195 | 2 | 3.90.850.10 | |
| Domain | IG_LIKE | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 VCAN CRTAM CD96 MYBPC3 | 6.71e-04 | 491 | 195 | 14 | PS50835 |
| Domain | EGF | 8.35e-04 | 235 | 195 | 9 | SM00181 | |
| Domain | Ig-like_dom | PRTG CEACAM5 MYOM1 VSIG4 ALCAM VCAM1 CNTN4 FLT1 DSCAM CD22 VCAN CRTAM CD96 MYBPC3 | 8.47e-04 | 503 | 195 | 14 | IPR007110 |
| Domain | IGv | 1.13e-03 | 75 | 195 | 5 | SM00406 | |
| Domain | EGF-like_dom | 1.25e-03 | 249 | 195 | 9 | IPR000742 | |
| Domain | EGF_1 | 1.48e-03 | 255 | 195 | 9 | PS00022 | |
| Domain | RIH_assoc-dom | 1.58e-03 | 6 | 195 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.58e-03 | 6 | 195 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.58e-03 | 6 | 195 | 2 | PF08454 | |
| Domain | RIH_dom | 1.58e-03 | 6 | 195 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.58e-03 | 6 | 195 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.58e-03 | 6 | 195 | 2 | IPR015925 | |
| Domain | - | 1.58e-03 | 6 | 195 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.58e-03 | 6 | 195 | 2 | PF01365 | |
| Domain | ACTININ_2 | 1.70e-03 | 23 | 195 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.70e-03 | 23 | 195 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.70e-03 | 23 | 195 | 3 | IPR001589 | |
| Domain | zf-CCHC | 1.70e-03 | 23 | 195 | 3 | PF00098 | |
| Domain | EGF-like_CS | 1.73e-03 | 261 | 195 | 9 | IPR013032 | |
| Pubmed | SLK MAP4 CD2AP RGPD1 TMOD3 ACSL3 ZC3H11A FKBP3 RGPD5 FLNA FLNC RGPD8 ARFGEF1 EIF4G1 SNRNP200 | 3.69e-12 | 215 | 206 | 15 | 35973513 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SLK ACACA MAP4 RPP40 PPP1R12A CD2AP GARS1 TMOD3 SCRN1 CMYA5 ZZEF1 WNK1 CLIP1 CLU GCLC HECTD1 FKBP3 FLNA FLNC NIBAN1 HYOU1 OXR1 COPG1 PPP4R3A LIG1 DPP9 PRPF4 CSNK2A2 EIF4G1 H1-5 POLD3 DCTN4 SNRNP200 | 3.62e-11 | 1455 | 206 | 33 | 22863883 |
| Pubmed | SRRM1 ACACA MAP4 LARP4 ITPR3 CEP170 ACSL3 ZC3H11A DST HECTD1 FLNA FLNC HYOU1 COPG1 ZCCHC8 POLE TUT7 CSNK2A2 EIF4G1 SPEN SNRNP200 | 4.23e-10 | 653 | 206 | 21 | 22586326 | |
| Pubmed | HIVEP1 ACACA CD2AP RGPD1 RREB1 DST ALMS1 BRCA2 RAF1 FLNA SIN3B RGPD8 L3MBTL2 ZCCHC8 JMJD1C ZNF532 KAT14 | 6.42e-10 | 418 | 206 | 17 | 34709266 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ACACA MAP4 CD2AP TMOD3 LARP4 EMSY CEP170 TLK1 ZC3H11A BRCA2 PCNP FLNA FLNC JMJD1C PRPF4 EIF4G1 POLD3 | 1.60e-09 | 444 | 206 | 17 | 34795231 |
| Pubmed | A2M SLK DENND4A ERGIC2 ZZEF1 ITPR1 DST CLU SUPV3L1 METTL16 PZP RAF1 HYOU1 POLE TUT7 RALGAPB DDX55 JMJD1C SACM1L ZBED1 | 2.39e-09 | 650 | 206 | 20 | 38777146 | |
| Pubmed | KIAA0408 DENND4A HIVEP1 MYOM1 CMYA5 WNK1 CLIP1 ASAP1 CEP170 DST ALMS1 PIK3C2A ZBTB40 HSPB8 ARMT1 FLNC JMJD1C | 8.54e-09 | 497 | 206 | 17 | 23414517 | |
| Pubmed | HIVEP1 MAP4 GARS1 PTPN22 GABARAPL2 RREB1 EMSY CEP170 TLK1 ZC3H11A ZBTB40 FKBP3 PCNP FLNA SIN3B HYOU1 DDX55 JMJD1C PPP4R3A LIG1 PRPF4 CSNK2A2 H1-5 SPEN SNRNP200 | 1.09e-08 | 1103 | 206 | 25 | 34189442 | |
| Pubmed | ADGRB3 SCRN1 WNK1 TLK1 DST ALMS1 ZBTB40 RALGAPB CADPS CHD5 STK38L SNRNP200 | 1.17e-08 | 225 | 206 | 12 | 12168954 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 HIVEP1 ACACA MAP4 RREB1 CLIP1 EMSY ACSL3 TLK1 ZC3H11A ZBTB40 FLNA ZCCHC8 RALGAPB PPP4R3A LIG1 CSNK2A2 EIF4G1 SPEN SNRNP200 | 4.35e-08 | 774 | 206 | 20 | 15302935 |
| Pubmed | A2M CLU PTPRZ1 AGT ALCAM PZP VCAM1 CNTN4 HYOU1 APOB APOD SERPINA6 | 5.08e-08 | 257 | 206 | 12 | 16335952 | |
| Pubmed | SLK MAP4 CD2AP HM13 ITPR1 ITPR3 CEP170 ACSL3 DST PRR14L PCNP FLNA FLNC COPG1 EIF4G1 STEAP3 PLEKHA1 | 5.93e-08 | 568 | 206 | 17 | 37774976 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK ACACA MAP4 PPP1R12A CD2AP LARP4 CEP170 PIK3C2A FKBP3 PCNP FLNA FLNC TUT4 HYOU1 COPG1 DDX55 EIF4G1 H1-5 SPEN | 7.57e-08 | 724 | 206 | 19 | 36232890 |
| Pubmed | TMOD3 HMGCR RREB1 HM13 LARP4 WNK1 FRMD4B CEP170 ALMS1 PRR14L HECTD1 TUT4 HYOU1 RGPD8 L3MBTL2 TUT7 JMJD1C STEAP3 POLD3 | 9.17e-08 | 733 | 206 | 19 | 34672954 | |
| Pubmed | SLK MAP4 PPP1R12A TMOD3 SCRN1 GABARAPL2 PTGS2 ASAP1 CEP170 DST CLU PTPRZ1 RAF1 FLNA FLNC HYOU1 OXR1 SACM1L ARHGAP5 CADPS CSNK2A2 VCAN EIF4G1 DCTN4 SLC4A4 TNR SNRNP200 | 1.17e-07 | 1431 | 206 | 27 | 37142655 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.40e-07 | 137 | 206 | 9 | 37039823 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M SRRM1 SLK ACACA MAP4 CD2AP GARS1 WNK1 EMSY ASAP1 CEP170 ACSL3 ZC3H11A PIK3C2A SUPV3L1 ALCAM FKBP3 PCNP FLNA SIN3B FLNC HYOU1 COPG1 ARFGEF1 SACM1L EIF4G1 | 1.76e-07 | 1367 | 206 | 26 | 32687490 |
| Pubmed | SLK ACACA MAP4 PPP1R12A CD2AP EMSY CEP170 ZC3H11A ALMS1 RGPD5 PCNP FLNA SIN3B JMJD1C SPEN SNRNP200 | 2.11e-07 | 549 | 206 | 16 | 38280479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 DENND4A HIVEP1 ACACA MAP4 PPP1R12A CD2AP WNK1 CEP170 FSIP2 DST ALMS1 PIK3C2A HECTD1 RAF1 ZCCHC8 RALGAPB DNAH7 EIF4G1 PLEKHA1 | 2.40e-07 | 861 | 206 | 20 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ACACA MAP4 PPP1R12A CD2AP HM13 LARP4 CHRM3 BRWD3 CEP170 TLK1 ZC3H11A RIN2 SHPRH ALCAM HECTD1 TET3 NSMAF DOCK1 CACNB3 TUT4 RALGAPB APBB2 LAMA3 JMJD1C DPP9 ZNF532 STK38L | 2.56e-07 | 1489 | 206 | 27 | 28611215 |
| Pubmed | SRRM1 GARS1 TMOD3 ACSL3 CLU MYL6B VIL1 HYOU1 APOB EIF4G1 SNRNP200 | 2.63e-07 | 244 | 206 | 11 | 28902428 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SRRM1 DENND4A HIVEP1 MYOM1 MAP4 PTPN22 CEP170 CLU CPLANE1 SLC13A2 JMJD1C EIF4G1 SPEN | 2.84e-07 | 361 | 206 | 13 | 26167880 |
| Pubmed | SRRM1 DENND4A TTC16 PPP1R12A GARS1 RGPD1 LRRC43 ACSL3 TLK1 ACSM3 DST GCLC ALCAM RGPD5 VIL1 FLNA FLNC HYOU1 RGPD8 APOB DDX55 CHD5 EIF4G1 H1-5 SPEN ATPAF2 | 4.86e-07 | 1442 | 206 | 26 | 35575683 | |
| Pubmed | DENND4A WNK1 CLIP1 CEP170 ACSL3 DST ALMS1 PIK3C2A HECTD1 RAF1 ZCCHC8 RALGAPB PLEKHA1 STK38L | 5.15e-07 | 446 | 206 | 14 | 24255178 | |
| Pubmed | A2M CEACAM5 ACACA TMOD3 CLIP1 FSCB ITPR1 ACSL3 BRCA2 SHPRH PRAP1 FLNA TUT4 COPG1 APOB EIF4G1 H1-5 SNRNP200 | 6.68e-07 | 754 | 206 | 18 | 35906200 | |
| Pubmed | MAP4 PPP1R12A CD2AP NCKAP5 ASAP1 BRCA2 DOCK1 FLNA FLNC RALGAPB SPEN IL5RA | 7.20e-07 | 329 | 206 | 12 | 17474147 | |
| Pubmed | 8.16e-07 | 4 | 206 | 3 | 11163362 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 8.16e-07 | 4 | 206 | 3 | 14685260 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SLK ACACA MAP4 PPP1R12A TMOD3 WNK1 EMSY CEP170 ZC3H11A DST ALMS1 PRR14L FKBP3 PCNP FLNA SIN3B L3MBTL2 ZCCHC8 PPP4R3A SNRNP200 | 8.52e-07 | 934 | 206 | 20 | 33916271 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | MAP4 PPP1R12A RGPD1 ITPR1 ITPR3 CEP170 ZC3H11A MRPL16 FKBP3 PCNP RGPD8 ZCCHC8 TUT7 DDX55 CD22 CSNK2A2 H1-5 | 1.12e-06 | 701 | 206 | 17 | 30196744 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SRRM1 PPP1R12A TMOD3 ITPR3 CEP170 MYL6B RGPD5 VIL1 FLNA RGPD8 COPG1 EIF4G1 H1-5 LGR6 DCTN4 SNRNP200 | 1.19e-06 | 626 | 206 | 16 | 33644029 |
| Pubmed | 1.32e-06 | 92 | 206 | 7 | 37343697 | ||
| Pubmed | HIVEP1 NCKAP5 WNK1 ASAP1 TLK1 DST CPLANE1 DOCK1 FLNA FLNC LAMA3 PPP4R3A SLC4A4 SNRNP200 | 1.42e-06 | 486 | 206 | 14 | 20936779 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SRRM1 SLK ACACA MAP4 PPP1R12A CD2AP GARS1 TMOD3 CEP170 DST FKBP3 RAF1 FLNA FLNC HYOU1 COPG1 CSNK2A2 EIF4G1 POLD3 DCTN4 STK38L SNRNP200 | 1.50e-06 | 1149 | 206 | 22 | 35446349 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.57e-06 | 235 | 206 | 10 | 30258100 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M MAP4 PPP1R12A GARS1 TMOD3 ITPR3 CEP170 ZC3H11A DST MYL6B FKBP3 FLNA HYOU1 TUT7 LAMA3 DDX55 PRPF4 CSNK2A2 CHD5 EIF4G1 H1-5 SPEN SNRNP200 | 1.83e-06 | 1257 | 206 | 23 | 36526897 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 ACACA MAP4 GARS1 LARP4 ASAP1 ACSL3 ZC3H11A DST PIK3C2A SUPV3L1 PRR14L HSPB8 FLNA FLNC L3MBTL2 COPG1 POLE TUT7 EIF4G1 H1-5 POLD3 DCTN4 SNRNP200 | 1.84e-06 | 1353 | 206 | 24 | 29467282 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | A2M ACACA NCKAP5 LARP4 WNK1 FRMD4B ASAP1 ITPR1 DST MOCS1 FLNA CACNB3 | 2.01e-06 | 363 | 206 | 12 | 14691545 |
| Pubmed | Intestinal SURF4 is essential for apolipoprotein transport and lipoprotein secretion. | 2.06e-06 | 16 | 206 | 4 | 38042368 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | SRRM1 GARS1 LARP4 CEP170 ZC3H11A ALMS1 PRR14L HECTD1 RAF1 ZCCHC8 CSNK2A2 POLD3 | 2.06e-06 | 364 | 206 | 12 | 24778252 |
| Pubmed | 2.39e-06 | 192 | 206 | 9 | 20602615 | ||
| Pubmed | SLK ACACA PPP1R12A GARS1 SCRN1 GABARAPL2 ERGIC2 HM13 LARP4 WNK1 CEP170 ACSL3 DST CLU HECTD1 FLNA HYOU1 COPG1 APOB DDX55 SACM1L CSNK2A2 H1-5 | 3.08e-06 | 1297 | 206 | 23 | 33545068 | |
| Pubmed | SRRM1 DENND4A PPP1R12A WNK1 CEP170 SHPRH HECTD1 FLNA STK38L SNRNP200 | 3.25e-06 | 255 | 206 | 10 | 15324660 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SLK MAP4 CD2AP CEP170 PCNP FLNA SIN3B JMJD1C EIF4G1 SNRNP200 | 3.37e-06 | 256 | 206 | 10 | 33397691 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.62e-06 | 202 | 206 | 9 | 33005030 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SRRM1 MIS18BP1 HIVEP1 RREB1 EMSY FSIP2 SHPRH ZBTB40 SIN3B L3MBTL2 DDX55 JMJD1C CSNK2A2 CHD5 SPEN | 3.96e-06 | 608 | 206 | 15 | 36089195 |
| Pubmed | Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. | 4.04e-06 | 6 | 206 | 3 | 17416589 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLK DENND4A HIVEP1 ACACA MAP4 GARS1 CMYA5 ACSL3 ZC3H11A GCLC SUPV3L1 FKBP3 FLNA HYOU1 COPG1 POLE APOB DDX55 SACM1L PRPF4 CSNK2A2 EIF4G1 SPEN SNRNP200 | 4.45e-06 | 1425 | 206 | 24 | 30948266 |
| Pubmed | ACACA MAP4 RGPD1 ADGRB3 SCRN1 HM13 ASAP1 ITPR1 CEP170 ACSL3 CLU PCNP FLNA TUT4 RGPD8 COPG1 SACM1L CADPS H1-5 POLD3 SLC4A4 | 4.70e-06 | 1139 | 206 | 21 | 36417873 | |
| Pubmed | MIS18BP1 EMSY ZC3H11A PCNP SIN3B L3MBTL2 ZCCHC8 JMJD1C PRPF4 SPEN SNRNP200 | 6.43e-06 | 339 | 206 | 11 | 30415952 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 7.04e-06 | 7 | 206 | 3 | 15710750 | |
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 15318112 | ||
| Pubmed | A2M SRRM1 MAP4 GARS1 HM13 LARP4 CLIP1 ADH1B CEP170 PIK3C2A MYL6B FKBP3 PCNP VIL1 RAF1 FLNA COPG1 TUT7 APOB DDX55 ARHGAP5 CSNK2A2 EIF4G1 | 7.61e-06 | 1371 | 206 | 23 | 36244648 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 7.80e-06 | 120 | 206 | 7 | 31413325 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 8.70e-06 | 47 | 206 | 5 | 14760718 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA ZZEF1 WNK1 ITPR3 ESRP2 TLK1 ZC3H11A DST NBEAL2 HECTD1 LRRC8E FLNA FLNC POLE CHD5 EIF4G1 LRP4 STEAP3 SPEN ATPAF2 | 1.05e-05 | 1105 | 206 | 20 | 35748872 |
| Pubmed | 1.12e-05 | 8 | 206 | 3 | 27412403 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRM1 ACACA MAP4 RGPD1 LARP4 PCNP HYOU1 RGPD8 COPG1 JMJD1C LIG1 CSNK2A2 EIF4G1 SPEN SNRNP200 | 1.15e-05 | 665 | 206 | 15 | 30457570 |
| Pubmed | SRRM1 PPP1R12A TMOD3 RREB1 ZZEF1 BRWD3 ACTL7A CEP170 ALMS1 CLU RAF1 TUT4 ZCCHC8 PRPF4 CADPS CSNK2A2 CHD5 H1-5 LRP4 KAT14 | 1.21e-05 | 1116 | 206 | 20 | 31753913 | |
| Pubmed | 1.32e-05 | 130 | 206 | 7 | 12421765 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIS18BP1 ACACA CD2AP RGPD1 CLIP1 EMSY ASAP1 ALMS1 BRCA2 MYL6B CPLANE1 HYOU1 L3MBTL2 TUT7 DNAH7 ARHGAP5 DCTN4 | 1.48e-05 | 853 | 206 | 17 | 28718761 |
| Pubmed | SLK PPP1R12A TRPC4 RGPD1 ADGRB3 CLIP1 EMSY CEP170 DST CLU CNTN4 SIN3B RGPD8 DSCAM CSNK2A2 EIF4G1 SLC4A4 TNR | 1.94e-05 | 963 | 206 | 18 | 28671696 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PPP1R12A CD2AP GARS1 RGPD1 TMOD3 ERGIC2 CLIP1 ITPR1 CEP170 TLK1 MRPL16 CLU RGPD5 RGPD8 L3MBTL2 COPG1 PRPF4 EIF4G1 DCTN4 SNRNP200 | 1.98e-05 | 1155 | 206 | 20 | 20360068 |
| Pubmed | 1.98e-05 | 191 | 206 | 8 | 33762435 | ||
| Pubmed | MAP4 PPP1R12A CD2AP WNK1 PTGS2 ASAP1 ITPR1 ZC3H11A ZBTB40 CPLANE1 PCNP ARMT1 FLNA HYOU1 TUT7 APOB ARHGAP5 CSNK2A2 VCAN | 2.73e-05 | 1084 | 206 | 19 | 11544199 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SRRM1 MIS18BP1 GARS1 HM13 LARP4 ZZEF1 ITPR1 ITPR3 ACSL3 DST ALMS1 MRPL16 PIK3C2A SUPV3L1 RAF1 TUT4 HYOU1 RGPD8 ZCCHC8 POLE TUT7 DDX55 ATPAF2 | 3.01e-05 | 1496 | 206 | 23 | 32877691 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | A2M SRRM1 ACACA PPP1R12A TRPC4 GARS1 ACSL3 DST FLNA FLNC HYOU1 SNRNP200 | 3.09e-05 | 477 | 206 | 12 | 31300519 |
| Pubmed | 3.26e-05 | 11 | 206 | 3 | 19105203 | ||
| Pubmed | Developmental basis for filamin-A-associated myxomatous mitral valve disease. | 3.26e-05 | 11 | 206 | 3 | 22843703 | |
| Pubmed | A2M SRRM1 SLK MIS18BP1 PPP1R12A CD2AP WNK1 CEP170 DST ALMS1 SHPRH DDX55 CSNK2A2 SPEN | 3.44e-05 | 645 | 206 | 14 | 25281560 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 8201622 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 30191727 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22726658 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 1973682 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 15890645 | ||
| Pubmed | Basic Tilted Helix Bundle - a new protein fold in human FKBP25/FKBP3 and HectD1. | 3.49e-05 | 2 | 206 | 2 | 24667607 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 20357489 | ||
| Pubmed | Alcohol-metabolizing genes and alcohol phenotypes in an Israeli household sample. | 3.49e-05 | 2 | 206 | 2 | 23895337 | |
| Pubmed | TUT4/7-mediated uridylation of a coronavirus subgenomic RNAs delays viral replication. | 3.49e-05 | 2 | 206 | 2 | 37085578 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 3.49e-05 | 2 | 206 | 2 | 10973822 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 3375073 | ||
| Pubmed | Alcohol drinking habits, alcohol dehydrogenase genotypes and risk of acute coronary syndrome. | 3.49e-05 | 2 | 206 | 2 | 20494945 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 3397059 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22048268 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 19550411 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 10679933 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 20626887 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 24795349 | ||
| Pubmed | Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease. | 3.49e-05 | 2 | 206 | 2 | 36685605 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 24675808 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 3.49e-05 | 2 | 206 | 2 | 24469451 | |
| Pubmed | The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. | 3.49e-05 | 2 | 206 | 2 | 28665939 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 34949722 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 20434443 | ||
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 3.49e-05 | 2 | 206 | 2 | 8663526 | |
| Pubmed | Alcohol-metabolizing enzyme gene polymorphisms in the Basque Country, Morocco, and Ecuador. | 3.49e-05 | 2 | 206 | 2 | 21303386 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 25208201 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 16184481 | ||
| Pubmed | ADH genotype does not modify the effects of alcohol on high-density lipoprotein. | 3.49e-05 | 2 | 206 | 2 | 12658118 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 17134660 | ||
| Interaction | NUP43 interactions | SRRM1 MIS18BP1 HIVEP1 ACACA MAP4 PPP1R12A EMSY FSIP2 DST BRCA2 RGPD5 FLNA RGPD8 DSCAM L3MBTL2 DDX55 JMJD1C ZNF532 EIF4G1 SPEN SNRNP200 | 1.07e-06 | 625 | 199 | 21 | int:NUP43 |
| Interaction | SIRT7 interactions | SRRM1 ACACA MAP4 LARP4 ITPR3 CEP170 ACSL3 ZC3H11A DST HECTD1 NR0B2 RAF1 FLNA FLNC HYOU1 COPG1 ZCCHC8 POLE TUT7 CSNK2A2 EIF4G1 SPEN SNRNP200 | 1.34e-06 | 744 | 199 | 23 | int:SIRT7 |
| Interaction | RCOR1 interactions | HIVEP1 ACACA PPP1R12A CD2AP RREB1 DST ALMS1 BRCA2 FLNA SIN3B L3MBTL2 ZCCHC8 JMJD1C PPP4R3A CSNK2A2 SPEN KAT14 | 8.77e-06 | 494 | 199 | 17 | int:RCOR1 |
| Interaction | GUSBP5 interactions | 9.27e-06 | 75 | 199 | 7 | int:GUSBP5 | |
| Interaction | CABP1 interactions | 1.16e-05 | 15 | 199 | 4 | int:CABP1 | |
| Interaction | RAB4A interactions | DENND4A CD2AP SCRN1 HM13 DMXL1 ITPR3 ACSL3 DST RAF1 OXR1 RALGAPB ARFGEF1 SLC20A2 LRP4 STEAP3 PLEKHA1 | 1.32e-05 | 457 | 199 | 16 | int:RAB4A |
| Interaction | MYH9 interactions | DENND4A HIVEP1 ACACA MYOM1 TTC16 PPP1R12A TMOD3 WNK1 ITPR3 DST PIK3C2A MYL6B VCAM1 RAF1 FLNA ARFGEF1 APOB PRPF4 EIF4G1 STK38L MYBPC3 | 1.93e-05 | 754 | 199 | 21 | int:MYH9 |
| Interaction | RICTOR interactions | SLK MAP4 CD2AP RGPD1 TMOD3 HMGCR ACSL3 ZC3H11A FKBP3 HSPB8 RGPD5 FLNA FLNC NIBAN1 HYOU1 RGPD8 COPG1 ARFGEF1 EIF4G1 H1-5 SNRNP200 | 2.13e-05 | 759 | 199 | 21 | int:RICTOR |
| Interaction | MTA2 interactions | MAP4 CD2AP TMOD3 BRCA2 SHPRH HECTD1 FKBP3 RAF1 SIN3B L3MBTL2 PPP4R3A CSNK2A2 CHD5 ZBED1 SPEN | 2.94e-05 | 435 | 199 | 15 | int:MTA2 |
| Interaction | PHF21A interactions | HIVEP1 ACACA RREB1 DST ALMS1 BRCA2 RAF1 FLNA SIN3B L3MBTL2 ZCCHC8 JMJD1C KAT14 | 3.87e-05 | 343 | 199 | 13 | int:PHF21A |
| Cytoband | 14q21.2 | 9.59e-05 | 20 | 206 | 3 | 14q21.2 | |
| Cytoband | 12q24.3 | 2.97e-04 | 6 | 206 | 2 | 12q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 6.18e-04 | 415 | 206 | 8 | chr12q24 | |
| Cytoband | 7q22 | 6.69e-04 | 38 | 206 | 3 | 7q22 | |
| GeneFamily | Fibronectin type III domain containing | 4.97e-05 | 160 | 147 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.19e-05 | 161 | 147 | 8 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.83e-04 | 193 | 147 | 8 | 594 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.96e-04 | 3 | 147 | 2 | 297 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.05e-04 | 40 | 147 | 4 | 592 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.06e-03 | 25 | 147 | 3 | 74 | |
| GeneFamily | Non-canonical poly(A) polymerases | 1.34e-03 | 7 | 147 | 2 | 1318 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.78e-03 | 8 | 147 | 2 | 658 | |
| GeneFamily | Alcohol dehydrogenases | 1.78e-03 | 8 | 147 | 2 | 397 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.28e-03 | 9 | 147 | 2 | 1234 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.28e-03 | 9 | 147 | 2 | 1230 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.44e-03 | 11 | 147 | 2 | 1168 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 4.11e-03 | 12 | 147 | 2 | 1243 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK HIVEP1 PPP1R12A CD2AP LARP4 ZZEF1 CLIP1 ITPR1 CEP170 ACSL3 TLK1 DST BRCA2 PIK3C2A RIN2 ALCAM NSMAF DOCK1 TUT4 APBB2 ARFGEF1 SLC20A2 SPEN | 2.40e-07 | 856 | 203 | 23 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | CD2AP CLIP1 TLK1 DST ALMS1 BRCA2 FLNA ARFGEF1 ARHGAP5 STK38L | 3.73e-06 | 199 | 203 | 10 | M5893 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLK MIS18BP1 ERGIC2 CLIP1 DMXL1 ITPR1 CEP170 CPLANE1 HECTD1 ARMT1 TUT4 TUT7 FAHD2A ARFGEF1 SACM1L ARHGAP5 PRPF4 | 1.54e-05 | 656 | 203 | 17 | M18979 |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.89e-05 | 71 | 203 | 6 | M2948 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 2.45e-05 | 197 | 203 | 9 | M3193 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.66e-05 | 199 | 203 | 9 | M3197 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN | 2.76e-05 | 200 | 203 | 9 | M4527 | |
| Coexpression | HALLMARK_MYOGENESIS | 2.76e-05 | 200 | 203 | 9 | M5909 | |
| Coexpression | GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN | SLC46A2 ERGIC2 CLIP1 ZC3H11A SHPRH VCAM1 COPG1 ARFGEF1 ARHGAP5 | 2.76e-05 | 200 | 203 | 9 | M4104 |
| Coexpression | PILON_KLF1_TARGETS_UP | A2M MIS18BP1 EMSY ASAP1 TLK1 CLU ALCAM HECTD1 VCAM1 FLT1 RALGAPB APOB SERPINA6 LGR6 | 4.13e-05 | 503 | 203 | 14 | M2226 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 4.99e-05 | 167 | 203 | 8 | M2995 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_ASTROCYTES | 5.66e-05 | 170 | 203 | 8 | M40162 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | PTPN22 CHRM3 PTGS2 ADH1B DST PTPRZ1 TET3 VCAM1 FLNA SFRP4 SLC34A2 APOD ZNF532 VCAN CD96 | 5.79e-05 | 587 | 203 | 15 | M17572 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 6.27e-05 | 276 | 203 | 10 | M3063 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SLK HIVEP1 PPP1R12A CD2AP LARP4 CLIP1 CEP170 ACSL3 TLK1 DST TUT4 ARFGEF1 SPEN | 7.61e-05 | 466 | 203 | 13 | M13522 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | SRRM1 SLK MIS18BP1 RREB1 DST ANKRD13C RIN2 ALCAM PCNP OXR1 ZNF532 | 8.30e-05 | 344 | 203 | 11 | M2239 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 8.78e-05 | 181 | 203 | 8 | M39225 | |
| Coexpression | PILON_KLF1_TARGETS_UP | A2M MIS18BP1 EMSY ASAP1 TLK1 CLU ALCAM HECTD1 VCAM1 FLT1 RALGAPB APOB SERPINA6 LGR6 | 8.97e-05 | 541 | 203 | 14 | MM1061 |
| Coexpression | ATF2_S_UP.V1_DN | 1.10e-04 | 187 | 203 | 8 | M2681 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 1.14e-04 | 188 | 203 | 8 | M7940 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP | 1.58e-04 | 197 | 203 | 8 | M7264 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP | 1.58e-04 | 197 | 203 | 8 | M7930 | |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.63e-04 | 198 | 203 | 8 | M7200 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 1.69e-04 | 199 | 203 | 8 | M5970 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN | 1.69e-04 | 199 | 203 | 8 | M3709 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 1.75e-04 | 200 | 203 | 8 | M3377 | |
| Coexpression | GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN | 1.75e-04 | 200 | 203 | 8 | M8584 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 1.75e-04 | 200 | 203 | 8 | M5128 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_DN | 1.75e-04 | 200 | 203 | 8 | M5176 | |
| Coexpression | GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN | 1.75e-04 | 200 | 203 | 8 | M4114 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 1.58e-05 | 117 | 201 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | MYOM1 PPP1R12A ERGIC2 ITPR1 ADRA2A PIK3C2A CPLANE1 HSPB8 DOCK1 CNTN4 TUT4 CADPS VCAN DCTN4 | 2.44e-05 | 393 | 201 | 14 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | PPP1R12A CD2AP ERGIC2 ITPR1 ADRA2A PIK3C2A SHPRH CPLANE1 DOCK1 TUT4 | 2.48e-05 | 203 | 201 | 10 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIAA0408 SRRM1 PRTG MIS18BP1 ADGRB3 TMOD3 HMGCR ERGIC2 HM13 LARP4 FRMD4B BRWD3 DMXL1 CEP170 ZC3H11A PTPRZ1 CPLANE1 TUT4 JMJD1C CADPS EIF4G1 | 3.28e-05 | 815 | 201 | 21 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | FRMD4B PTGS2 ASAP1 DST CLU RIN2 ALCAM VCAM1 DOCK1 CACNB3 NIBAN1 DSCAM JMJD1C CD22 | 3.57e-05 | 407 | 201 | 14 | GSM538245_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 3.63e-05 | 40 | 201 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | PPP1R12A CD2AP ERGIC2 ADRA2A PIK3C2A SHPRH PLAG1 CPLANE1 DOCK1 TUT4 VCAN | 4.12e-05 | 261 | 201 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_100 | 4.67e-05 | 100 | 201 | 7 | PCBC_ctl_geo-heart_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | MYOM1 PPP1R12A BRWD3 SHPRH ALCAM CPLANE1 VCAM1 DOCK1 LRRC8E CNTN4 NIBAN1 VCAN EIF4G1 DCTN4 | 5.15e-05 | 421 | 201 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SRRM1 SLK PPP1R12A NCKAP5 WNK1 CLIP1 FRMD4B ABHD17C CEP170 PTPRZ1 HECTD1 ASTE1 ARFGEF1 ARHGAP5 LIG1 EFCAB7 SNRNP200 | 5.47e-05 | 595 | 201 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | MYOM1 PPP1R12A LARP4 TNMD CLIP1 BRWD3 CEP170 PIK3C2A SHPRH ALCAM CPLANE1 VCAM1 DOCK1 LRRC8E CNTN4 NIBAN1 FLT1 VCAN EIF4G1 DCTN4 | 9.28e-05 | 811 | 201 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SRRM1 SLK HIVEP1 PPP1R12A LARP4 WNK1 CLIP1 BRWD3 CEP170 ZC3H11A HECTD1 ASTE1 ARFGEF1 JMJD1C ARHGAP5 LIG1 | 9.89e-05 | 564 | 201 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.66e-04 | 163 | 201 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | A2M TTC16 NBEAL2 PZP FLNA TRGC1 TRGC2 LAMA3 SLC4A4 EFCAB7 CD96 | 6.37e-10 | 176 | 205 | 11 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | A2M PPP1R12A TRPC4 CHRM3 ITPR1 CNTN4 FLNA NIBAN1 LAMA3 LGR6 STK38L | 9.64e-10 | 183 | 205 | 11 | cae2ee08f985a6f005b4b8e959e465350315156a |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | A2M PPP1R12A TRPC4 CHRM3 ITPR1 CNTN4 FLNA NIBAN1 LAMA3 SLC20A2 STK38L | 1.28e-09 | 188 | 205 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | KIAA0408 CEACAM5 TMOD3 NCKAP5 PTGS2 DST ALCAM LAMA3 SLC6A4 ARHGAP5 PLEKHA1 | 2.10e-09 | 197 | 205 | 11 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-08 | 182 | 205 | 10 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-08 | 182 | 205 | 10 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-08 | 182 | 205 | 10 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-08 | 182 | 205 | 10 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.41e-08 | 183 | 205 | 10 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-08 | 187 | 205 | 10 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-08 | 187 | 205 | 10 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.34e-08 | 193 | 205 | 10 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.53e-08 | 167 | 205 | 9 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.04e-07 | 171 | 205 | 9 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 356C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-07 | 177 | 205 | 9 | 7ddd7d1854ad42abd630ad0c702105102cec93e7 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-07 | 180 | 205 | 9 | cedbe692c5257fb6f9a552e2f197163626ac17d9 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-07 | 183 | 205 | 9 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 185 | 205 | 9 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 185 | 205 | 9 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 185 | 205 | 9 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 185 | 205 | 9 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 185 | 205 | 9 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.04e-07 | 185 | 205 | 9 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-07 | 187 | 205 | 9 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-07 | 187 | 205 | 9 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.45e-07 | 189 | 205 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-07 | 189 | 205 | 9 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Severe-CD8+_T|Severe / Disease group and Cell class | 2.50e-07 | 93 | 205 | 7 | 433d23253b2102cf65df338a488554e5ab409d7e | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.79e-07 | 192 | 205 | 9 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.79e-07 | 192 | 205 | 9 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.79e-07 | 192 | 205 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.92e-07 | 193 | 205 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-07 | 193 | 205 | 9 | 523e2541f9f8d22b3c5263839a57cc1ab23d4963 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.18e-07 | 195 | 205 | 9 | 42382653e977714bff453bece26a6cd66ea2cc1f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-07 | 197 | 205 | 9 | a44501cac24c2f4a53b413e92bd060eed6514616 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-07 | 197 | 205 | 9 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.47e-07 | 197 | 205 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 3.47e-07 | 197 | 205 | 9 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.62e-07 | 198 | 205 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-07 | 198 | 205 | 9 | 686d973483d027a3ffa2ad4430ba6e50f3d1378e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-07 | 198 | 205 | 9 | a76366611f3561fc8aca7d62d1f0a0ea2bef7792 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.62e-07 | 198 | 205 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.62e-07 | 198 | 205 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.62e-07 | 198 | 205 | 9 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-07 | 198 | 205 | 9 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.78e-07 | 199 | 205 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 199 | 205 | 9 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.94e-07 | 200 | 205 | 9 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.94e-07 | 200 | 205 | 9 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.94e-07 | 200 | 205 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.94e-07 | 200 | 205 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.42e-07 | 152 | 205 | 8 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 6.28e-07 | 155 | 205 | 8 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.28e-07 | 155 | 205 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 6.92e-07 | 157 | 205 | 8 | af6eb2214340847bbab7cb209ea27cdc83b62a27 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.01e-06 | 165 | 205 | 8 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.21e-06 | 169 | 205 | 8 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-06 | 173 | 205 | 8 | b75353fcbc9f8cdb21d4f10ddbc93a83fd797a3c | |
| ToppCell | 356C-Lymphocytic-ILC|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-06 | 175 | 205 | 8 | 7fa8330ce813c48bd332be618909e5ec8d0f5d7e | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.71e-06 | 177 | 205 | 8 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.71e-06 | 177 | 205 | 8 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-06 | 177 | 205 | 8 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 177 | 205 | 8 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 178 | 205 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-06 | 178 | 205 | 8 | 40df4bb0978e5e5568c52ad4a5881ea0cdc6941d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 179 | 205 | 8 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 180 | 205 | 8 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 180 | 205 | 8 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-06 | 182 | 205 | 8 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 2.10e-06 | 182 | 205 | 8 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.10e-06 | 182 | 205 | 8 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.10e-06 | 182 | 205 | 8 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-06 | 182 | 205 | 8 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-06 | 184 | 205 | 8 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.28e-06 | 184 | 205 | 8 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.37e-06 | 185 | 205 | 8 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 185 | 205 | 8 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 185 | 205 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 185 | 205 | 8 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 186 | 205 | 8 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 186 | 205 | 8 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.57e-06 | 187 | 205 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-06 | 188 | 205 | 8 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-06 | 188 | 205 | 8 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.78e-06 | 189 | 205 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-06 | 189 | 205 | 8 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-06 | 189 | 205 | 8 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 2.78e-06 | 189 | 205 | 8 | e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-06 | 189 | 205 | 8 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-06 | 190 | 205 | 8 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-06 | 190 | 205 | 8 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.89e-06 | 190 | 205 | 8 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-06 | 190 | 205 | 8 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.01e-06 | 191 | 205 | 8 | ff7204f9b645233548cf804cf6fe0c86417be87f | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 3.01e-06 | 191 | 205 | 8 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-06 | 191 | 205 | 8 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 3.01e-06 | 191 | 205 | 8 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-06 | 191 | 205 | 8 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 192 | 205 | 8 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.13e-06 | 192 | 205 | 8 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| Drug | scopolamine | 1.84e-06 | 200 | 202 | 11 | CID000005184 | |
| Drug | bumetanide | SLC46A2 PTGS2 ACTL7A CLU GCLC AGT SLC34A2 SLC13A2 SLC6A4 SLC20A2 SLC4A4 | 2.82e-06 | 209 | 202 | 11 | CID000002471 |
| Drug | geldanamycin | MIS18BP1 TMOD3 LARP4 CLIP1 PTGS2 TLK1 ZC3H11A DST PRR14L METTL16 HECTD1 RAF1 FLT1 JMJD1C | 6.26e-06 | 371 | 202 | 14 | ctd:C001277 |
| Drug | genistein | MUC3B MAP4 GABARAPL2 PTGS2 ITPR1 ITPR3 ACTL7A PAOX DST BRCA2 PIK3C2A MYL6B AGT PZP VCAM1 RAF1 CACNB3 FLT1 SFRP4 LAMA3 APOB APOD SLC6A4 H1-5 MUC3A KAT14 | 6.90e-06 | 1117 | 202 | 26 | CID005280961 |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | MIS18BP1 MAP4 WNK1 PAOX TLK1 PRR14L METTL16 APBB2 APOD EIF4G1 | 1.06e-05 | 196 | 202 | 10 | 4108_DN |
| Drug | laurina | 1.31e-05 | 17 | 202 | 4 | CID000062957 | |
| Disease | Colorectal Carcinoma | ACACA WNK1 PTGS2 ADH1B PZP CNTN4 FLNC SFRP4 POLE ARFGEF1 APOB LIG1 CHD5 EIF4G1 H1-5 LGR6 POLD3 SNRNP200 | 1.38e-06 | 702 | 198 | 18 | C0009402 |
| Disease | Drugs used in diabetes use measurement | ZC3H11B PTPN22 RREB1 ZZEF1 ADRA2A DNAH7 JMJD1C PPP4R3A PLEKHA1 | 6.06e-05 | 255 | 198 | 9 | EFO_0009924 |
| Disease | Drug-Induced Liver Disease | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C0860207 |
| Disease | Chemical and Drug Induced Liver Injury | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C4277682 |
| Disease | Drug-Induced Acute Liver Injury | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C3658290 |
| Disease | Hepatitis, Toxic | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C0019193 |
| Disease | Chemically-Induced Liver Toxicity | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C4279912 |
| Disease | Hepatitis, Drug-Induced | CHRM3 PTGS2 ITPR1 CLU GCLC AGT PZP NR0B2 TCTN1 FLT1 SERPINA6 | 9.76e-05 | 404 | 198 | 11 | C1262760 |
| Disease | Cardiovascular Diseases | 9.79e-05 | 36 | 198 | 4 | C0007222 | |
| Disease | Malignant Glioma | 1.10e-04 | 70 | 198 | 5 | C0555198 | |
| Disease | mixed gliomas | 1.10e-04 | 70 | 198 | 5 | C0259783 | |
| Disease | Cognition Disorders | 1.21e-04 | 38 | 198 | 4 | C0009241 | |
| Disease | Prescription Drug Abuse | 1.30e-04 | 115 | 198 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 1.30e-04 | 115 | 198 | 6 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.30e-04 | 115 | 198 | 6 | C0029231 | |
| Disease | Drug habituation | 1.30e-04 | 115 | 198 | 6 | C0013170 | |
| Disease | Drug abuse | 1.30e-04 | 115 | 198 | 6 | C0013146 | |
| Disease | Drug Use Disorders | 1.30e-04 | 115 | 198 | 6 | C0013222 | |
| Disease | Drug Dependence | 1.30e-04 | 115 | 198 | 6 | C1510472 | |
| Disease | Substance Dependence | 1.30e-04 | 115 | 198 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 1.30e-04 | 115 | 198 | 6 | C0038586 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Xeroderma | 1.34e-04 | 3 | 198 | 2 | C0043345 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Substance abuse problem | 1.36e-04 | 116 | 198 | 6 | C0740858 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.56e-04 | 16 | 198 | 3 | C0751885 | |
| Disease | alcohol use disorder (is_implicated_in) | 1.56e-04 | 16 | 198 | 3 | DOID:1574 (is_implicated_in) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.89e-04 | 17 | 198 | 3 | C0751883 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.66e-04 | 19 | 198 | 3 | C0751884 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 2.66e-04 | 19 | 198 | 3 | MONDO_0018469 | |
| Disease | acute respiratory distress syndrome | 2.66e-04 | 4 | 198 | 2 | EFO_1000637 | |
| Disease | Ichthyoses | 2.66e-04 | 4 | 198 | 2 | C0020757 | |
| Disease | TYPE 1 DIABETES MELLITUS | 2.66e-04 | 4 | 198 | 2 | 222100 | |
| Disease | Diabetes mellitus type 1 | 2.66e-04 | 4 | 198 | 2 | cv:C0011854 | |
| Disease | Glioma | 3.06e-04 | 87 | 198 | 5 | C0017638 | |
| Disease | diabetic retinopathy (is_implicated_in) | 3.56e-04 | 50 | 198 | 4 | DOID:8947 (is_implicated_in) | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.62e-04 | 21 | 198 | 3 | EFO_0006790, EFO_0008343 | |
| Disease | Alcohol dependence | 4.42e-04 | 5 | 198 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 4.42e-04 | 5 | 198 | 2 | 103780 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 4.78e-04 | 54 | 198 | 4 | DOID:6432 (implicated_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital | 5.43e-04 | 24 | 198 | 3 | C0751882 | |
| Disease | Colorectal Neoplasms | 5.97e-04 | 277 | 198 | 8 | C0009404 | |
| Disease | Disorder of eye | 5.98e-04 | 212 | 198 | 7 | C0015397 | |
| Disease | pre-eclampsia (is_implicated_in) | 6.14e-04 | 25 | 198 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Distal spinal muscular atrophy | 6.60e-04 | 6 | 198 | 2 | cv:C0393541 | |
| Disease | muscular disease (is_implicated_in) | 6.60e-04 | 6 | 198 | 2 | DOID:0080000 (is_implicated_in) | |
| Disease | Liver Cirrhosis | 6.65e-04 | 103 | 198 | 5 | C0023890 | |
| Disease | Malignant neoplasm of skin | 6.71e-04 | 59 | 198 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 6.71e-04 | 59 | 198 | 4 | C0037286 | |
| Disease | Fibrosis, Liver | 7.26e-04 | 105 | 198 | 5 | C0239946 | |
| Disease | peptide measurement | 8.59e-04 | 109 | 198 | 5 | EFO_0010520 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 8.61e-04 | 28 | 198 | 3 | DOID:784 (biomarker_via_orthology) | |
| Disease | body weight | HIVEP1 RGPD1 ADGRB3 ZZEF1 CLIP1 ABHD17C ITPR1 ADH1B ACSL3 RIN2 PCDH15 PLAG1 DOCK1 COPG1 CADPS TEX29 PLEKHA1 POLD3 CDH9 | 8.86e-04 | 1261 | 198 | 19 | EFO_0004338 |
| Disease | atherosclerosis (implicated_via_orthology) | 9.20e-04 | 7 | 198 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | SRRM1 SLK DENND4A HIVEP1 ZC3H11B RREB1 WNK1 DST PNPLA1 ZBTB40 METTL16 VIL1 JMJD1C PPP4R3A SLC20A2 | 9.34e-04 | 880 | 198 | 15 | EFO_0007978 |
| Disease | testosterone measurement | DENND4A ZC3H11B RREB1 LARP4 CHRNB1 GALNT13 ADH1B RIN2 METTL16 HS3ST4 VIL1 RAF1 ZAN DSCAM TUT7 JMJD1C SLC20A2 CRTAM RPE65 | 1.01e-03 | 1275 | 198 | 19 | EFO_0004908 |
| Disease | Epstein-Barr virus infection | 1.02e-03 | 66 | 198 | 4 | EFO_0000769 | |
| Disease | osteoarthritis, spine, body mass index | 1.22e-03 | 8 | 198 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | Alcoholic Intoxication | 1.28e-03 | 32 | 198 | 3 | C0001969 | |
| Disease | joint hypermobility measurement | 1.40e-03 | 33 | 198 | 3 | EFO_0007905 | |
| Disease | lung cancer (implicated_via_orthology) | 1.56e-03 | 9 | 198 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.56e-03 | 9 | 198 | 2 | DOID:988 (is_implicated_in) | |
| Disease | 22q11 partial monosomy syndrome | 1.56e-03 | 9 | 198 | 2 | C3266101 | |
| Disease | asparaginase hypersensitivity | 1.82e-03 | 77 | 198 | 4 | EFO_0004881 | |
| Disease | Hypertensive disease | 1.84e-03 | 190 | 198 | 6 | C0020538 | |
| Disease | tauopathy (implicated_via_orthology) | 1.95e-03 | 10 | 198 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | Aortic Aneurysm, Abdominal | 1.95e-03 | 10 | 198 | 2 | C0162871 | |
| Disease | Asymmetric crying face association | 1.95e-03 | 10 | 198 | 2 | C0431406 | |
| Disease | 22q11 Deletion Syndrome | 1.95e-03 | 10 | 198 | 2 | C2936346 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.12e-03 | 264 | 198 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Hypercholesterolemia | 2.28e-03 | 39 | 198 | 3 | C0020443 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 2.29e-03 | 136 | 198 | 5 | DOID:9352 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 2.31e-03 | 268 | 198 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Macrocephaly | 2.37e-03 | 11 | 198 | 2 | C0221355 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 2.37e-03 | 11 | 198 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | delta-5 desaturase measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0007764 | |
| Disease | Malignant neoplasm of breast | TRPC4 WNK1 CLIP1 FSCB PTGS2 EMSY ZC3H11A BRCA2 RAF1 FLNA FLT1 SLC2A5 ZNF532 CHD5 LGR6 SPEN | 2.52e-03 | 1074 | 198 | 16 | C0006142 |
| Disease | liver fibrosis measurement | 2.72e-03 | 86 | 198 | 4 | EFO_0010576 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 2.83e-03 | 12 | 198 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | macular retinal edema (is_marker_for) | 2.83e-03 | 12 | 198 | 2 | DOID:4449 (is_marker_for) | |
| Disease | Kidney Diseases | 2.96e-03 | 88 | 198 | 4 | C0022658 | |
| Disease | amyotrophic lateral sclerosis | 3.02e-03 | 145 | 198 | 5 | MONDO_0004976 | |
| Disease | Alcohol Use Disorder | 3.22e-03 | 44 | 198 | 3 | C0001956 | |
| Disease | Reactive Hyperemia | 3.33e-03 | 13 | 198 | 2 | C0178824 | |
| Disease | Active Hyperemia | 3.33e-03 | 13 | 198 | 2 | C0333233 | |
| Disease | alcohol and nicotine codependence | 3.33e-03 | 13 | 198 | 2 | EFO_0004776 | |
| Disease | Venous Engorgement | 3.33e-03 | 13 | 198 | 2 | C0042484 | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 3.33e-03 | 13 | 198 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | Hyperlipoproteinemia Type IIb | 3.33e-03 | 13 | 198 | 2 | C1704417 | |
| Disease | Hyperemia | 3.33e-03 | 13 | 198 | 2 | C0020452 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.34e-03 | 91 | 198 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | sexual dimorphism measurement | RGPD1 ZC3H11B HMGCR LRRC43 ZZEF1 CLIP1 ABHD17C PNPLA1 PLAG1 VIL1 SFRP4 TUT7 APOB JMJD1C SLC6A4 MYBPC3 | 3.36e-03 | 1106 | 198 | 16 | EFO_0021796 |
| Disease | Malignant neoplasm of kidney | 3.43e-03 | 45 | 198 | 3 | C0740457 | |
| Disease | platelet aggregation | 3.43e-03 | 45 | 198 | 3 | GO_0070527 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.43e-03 | 45 | 198 | 3 | EFO_0022236 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.63e-03 | 291 | 198 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | alkaline phosphatase measurement | MAP4 PTPN22 ERGIC2 RREB1 ITPR1 ADH1B ADH1C TLK1 ZBTB40 PRR14L SFRP4 APOB JMJD1C STK38L MYBPC3 | 3.68e-03 | 1015 | 198 | 15 | EFO_0004533 |
| Disease | gastric ulcer (implicated_via_orthology) | 3.87e-03 | 14 | 198 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Kawasaki disease (is_marker_for) | 3.87e-03 | 14 | 198 | 2 | DOID:13378 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVNLTEPAKLEVKFS | 96 | P05090 | |
| LLKQKSEEPSVSIPF | 441 | Q5SW79 | |
| TDKPFIPLVEKFVDT | 71 | Q9H993 | |
| EKVANSPLSIKIFPT | 51 | Q5U5X8 | |
| LFKENSIVKVTVPPF | 46 | Q86W67 | |
| QVDFPTPKTELVQKF | 576 | Q92870 | |
| PSAKVVPTKFVSETD | 1696 | P13611 | |
| APIIVFVKVSSPKVL | 286 | P54284 | |
| DTPIVDPTVKFDKQP | 676 | Q8TDI0 | |
| IPKSIFTPVSSKELD | 741 | O60242 | |
| VAKKVPETSQAVPLI | 291 | P07510 | |
| PVSEKPLDTISQKSV | 1556 | Q9Y6D6 | |
| VTTVKPGDKVIPLFT | 81 | P00325 | |
| VTTVKPGDKVIPLFT | 81 | P00326 | |
| VKTITVSAELPKPSI | 491 | P06731 | |
| SLVKELDAFPKVPES | 11 | Q96RQ1 | |
| PKSFSKLPIQLESAV | 421 | P20309 | |
| TLKVTAIPEPADQKT | 551 | Q8TCU4 | |
| VKLDIPVFPTITATV | 496 | Q8N6S4 | |
| KIEVQFPETVPTAKG | 226 | Q8IWV2 | |
| DKVPETSLSVPIIIK | 296 | P11230 | |
| KDPIDRIIEFVPTKT | 1916 | Q13085 | |
| NEPDSPIVKAAKIVT | 1221 | Q6RI45 | |
| VVFETFPEQKEPSLK | 306 | Q8IYA2 | |
| TAFLTPLEIKAKVET | 561 | Q9Y5K6 | |
| TPEPLKVTFKSQVKV | 336 | Q5BKX8 | |
| ESLAVKEKFIPPELS | 2416 | Q9Y485 | |
| ETLKVKQTILEPIPT | 446 | Q2TB18 | |
| LPKFEVQVTVPKIIT | 226 | P01023 | |
| APIQAKTSPVDEKAL | 61 | P01019 | |
| PKEPITDVSVIIKSL | 41 | Q7Z401 | |
| DVAVKILKVVDPTPE | 371 | P04049 | |
| EKEDSPFALKVQTVP | 1341 | P20742 | |
| ETTTKAVVSPPKFVF | 1526 | Q99666 | |
| ETTTKAVVSPPKFVF | 1526 | O14715 | |
| KVPITRTKSTPFELI | 441 | Q9Y2R2 | |
| TKTAKFKEVIPISDP | 241 | Q6IN85 | |
| PTKEDKEAFAIVSVP | 421 | Q14573 | |
| PAVKVKLFTESTGVL | 456 | Q9ULU8 | |
| STPSLKTVKVVIFQP | 436 | Q460N3 | |
| IKKKLVETDFSTPTP | 1076 | Q6P0N0 | |
| IAPAKDVAPSTVKEV | 486 | P27816 | |
| LKTPQAKLFTVPSEA | 71 | Q8N5M1 | |
| AAQSKEIIFLPSKEP | 811 | Q16787 | |
| KVASAEIEPPSTEKF | 251 | Q5H9T9 | |
| SPVKEDKEAFAIVPV | 421 | Q14643 | |
| KASSPELPVSVENIK | 686 | Q969R5 | |
| FPVTPEAVKSVLLVV | 801 | Q9HBX8 | |
| TKETPLFQKILPLSE | 311 | Q5JYT7 | |
| PPSISAEVEKIKEQI | 6071 | Q03001 | |
| KVEVIKPLVAETDTP | 396 | P04035 | |
| SPDFQSVTPKEKVTI | 26 | A0A0C4DH24 | |
| KKIQLPAEVDPVTVF | 141 | Q9UJY1 | |
| RKTVIKSPTVPEFQL | 751 | Q5HYC2 | |
| DIIASVVENKIPPSK | 2111 | Q15652 | |
| PVDVNTDTIPFKDKI | 476 | Q8NHQ9 | |
| PPIDKETVDKISNFV | 5341 | Q5CZC0 | |
| QEFISKSKIKLVPPT | 6221 | Q5CZC0 | |
| KETVPTLAPKTLSVA | 96 | Q8WW12 | |
| SPDFQSVTPKEKVTI | 26 | A0A0A0MT36 | |
| DDSFETKKTPVLPVT | 106 | O00443 | |
| SKFAFKVETTPPTVL | 106 | Q02505 | |
| FQAKKIPIVSSLADP | 346 | A8MUH7 | |
| IKAASKPTLDPIITV | 226 | Q9H8E8 | |
| FVVNVAPPLDLSKIK | 956 | Q14315 | |
| VVINVPIFKDKNTPS | 201 | P48506 | |
| KETVSKPYVTESPAE | 481 | Q8N8W4 | |
| IFSSLVPEVKIDSKP | 336 | Q6ZU52 | |
| EKPRKPITFVVLASV | 306 | Q86W50 | |
| FSVPDPELIKTVTIN | 566 | P35354 | |
| TVAKSFEAPIKLVFP | 231 | Q8TCT9 | |
| VPKEPIIFSKFASSI | 126 | Q96GK7 | |
| EKVVTEPPVVTLLDK | 211 | Q6NSJ5 | |
| IETTKLPLKFPDAET | 276 | Q07864 | |
| PILVETPKVDKISST | 1206 | P23471 | |
| TFEVAEAPVPSILKK | 106 | Q15466 | |
| FSLAPEVEVRVSKKP | 131 | Q8N3Z3 | |
| VPEEESSTAKAFKIP | 281 | Q9NZB8 | |
| FVKEPQDVTVTRKDP | 41 | Q2VWP7 | |
| KTKVYPDELPNTSVV | 106 | Q8IUC8 | |
| PGFIVVKKIEESETI | 626 | Q8N573 | |
| IVSNVPPTLVEKKIE | 1251 | Q96QU1 | |
| DLKTLPAFPTKTLQE | 201 | Q9Y2L6 | |
| IVPEQTIEIPSIKFS | 3856 | P04114 | |
| FPPDEFTSKKITTKI | 2031 | Q9ULT8 | |
| TLAEQAKLPATEKPV | 871 | Q9Y4L1 | |
| PVFTEVEKAKIENSP | 316 | Q5T8I9 | |
| EKISLLPPVNFTIKV | 26 | Q01344 | |
| PPVSELITKAVAASK | 41 | P16401 | |
| LPTIVNDVKLVFDPK | 801 | Q14185 | |
| DKNLVSIETVVPPKL | 1601 | P51587 | |
| LTPQQDSSVFIKPEK | 2326 | Q9H799 | |
| KVIVLATPFKPILEA | 111 | O95727 | |
| SPRTKKFPLTEEEIF | 21 | A8K855 | |
| VPKEPIIFSKFASSI | 126 | Q6P2I3 | |
| KELVQPFSSLFPKVE | 336 | Q86TI2 | |
| FDLVIPFTIKKGEIT | 1791 | P21333 | |
| SVPAIKKEQEPTAAL | 1176 | Q8N3K9 | |
| EEIKPFSPKIISLES | 1711 | Q8N3K9 | |
| EQTSSKALTVPFPEK | 1896 | Q8WXX0 | |
| AKIPPNAKLTFEVEL | 206 | Q00688 | |
| VVFETFPEQKEPSLK | 356 | Q3MJ40 | |
| PSIDKISKVTSPVLV | 256 | Q6PCB6 | |
| LDKATIPPEIFQKSS | 911 | Q9ULH1 | |
| LVVDKPEQTVKTFPL | 81 | Q9BSJ5 | |
| TVKDPVSKTPALVFE | 101 | P19784 | |
| KVPTTEKPTVTVNFR | 826 | Q04637 | |
| KTFAIKPEVAPELSE | 541 | Q9UH90 | |
| IPETTPIEEVKGLFK | 206 | Q71RC2 | |
| VSKTVLIPPELKTVE | 91 | Q5VTH9 | |
| KSVIFEPDSISQPII | 61 | Q92636 | |
| TESTPITAVKQPEKV | 591 | Q9Y678 | |
| SSSPVVLKEVPKAVV | 211 | Q7Z589 | |
| VLIKPKPVTFQATVV | 666 | Q7Z589 | |
| DPSKQTFTPKLVLLD | 86 | A6NNS2 | |
| IDSTILSPKQIKTPF | 236 | Q86X24 | |
| VVFETFPEQKEPSLK | 356 | A2RUR9 | |
| LKPETIKNVEEPFTE | 226 | Q8IXS0 | |
| DINSTAKVVVPPKEL | 351 | Q9UJW0 | |
| PKIKLPSVTSFILDT | 606 | P18858 | |
| TFELQEPSPQKEVTK | 176 | Q13183 | |
| VSTEVTLAVKKDVPP | 36 | Q9NTJ5 | |
| SKVQEAESPVFKELP | 261 | Q08357 | |
| KISVEDIDEPPVFTK | 371 | Q9ULB4 | |
| VFEAPTIVKVFKQPS | 121 | Q13740 | |
| TIVKVFKQPSKPEIV | 126 | Q13740 | |
| ALSPKKNIFISPVSI | 56 | P08185 | |
| TLSKKPEIPTFEVLA | 301 | Q9Y661 | |
| TPKLEIKVTPSDAIV | 241 | P20273 | |
| TALKTPTAVVAPVEK | 21 | P30622 | |
| PSEKAIFLFVDKTVP | 71 | P60520 | |
| VLFPVQKPKLLTTEE | 61 | Q96NZ9 | |
| IKEVDATNLPPTLKV | 161 | Q8N309 | |
| TFVDPVLTEATPKEK | 256 | Q5THK1 | |
| ETTTKAVVSPPKFVF | 1511 | P0DJD0 | |
| LPEDTVVFEKPVKTI | 236 | Q6QHF9 | |
| SKFAFKVETTPPTVL | 106 | Q9H195 | |
| ELITPEFISTFIKKG | 76 | O75818 | |
| TPKIISAFSEKVVSP | 406 | O60469 | |
| VPSFEDVSIPEKPKL | 36 | Q9NX20 | |
| KEDPISKSEIVVQFP | 216 | Q16518 | |
| IQVTPKDIKLTAFPS | 596 | P19320 | |
| IPVSIKKEPEVTVVS | 686 | Q9H2G2 | |
| TLVFPPEVPISEKAK | 341 | Q9Y2H1 | |
| KPTIFLPSIAETKLQ | 11 | P0CF51 | |
| KPTIFLPSIAETKLQ | 11 | P03986 | |
| QEIIFPPIKTDVTTV | 101 | P03986 | |
| PATTEVQRKKPSVAF | 986 | O14513 | |
| ATKTKAPDDLVAPVV | 11 | O43172 | |
| IFLIVPETKAKTFIE | 456 | P22732 | |
| LAVTKEAKVSTPPEL | 1876 | Q6ZNJ1 | |
| LKEPKTVNVVQFEPS | 486 | P41250 | |
| KNASVPTITAKIPEF | 221 | Q16819 | |
| DKEKIQALPTVPVTE | 206 | Q9BV68 | |
| IESLKKNPVTAVPVV | 556 | O75182 | |
| KPIEKEETVGIFSPL | 81 | Q149N8 | |
| DLVTAEKPIPLFVEK | 1266 | Q13017 | |
| SKIPNTSLFVPLTVK | 56 | Q8IYB8 | |
| KIVEQPTVSVTEPKL | 261 | Q15054 | |
| EPSSQLFSKPEVIKQ | 216 | Q9H6T0 | |
| KPFIFVDDVKLVPKT | 306 | Q12765 | |
| VKIETKDVPLTVLPS | 306 | O94993 | |
| TAEPQVKEPKTFTVE | 21 | Q8N434 | |
| FVALDPIEEKKVPLS | 281 | Q9Y615 | |
| SAVISFPPLISIEKK | 176 | P08913 | |
| AISASLEKFEIPVKI | 666 | O95573 | |
| PRKVEFIQELPKTIS | 556 | Q53FZ2 | |
| TVTVPVEVSRKNPKF | 416 | P10909 | |
| ATAPKLKPVNSEETV | 61 | Q8WW14 | |
| ATVIKKTINTDFPFP | 396 | O95436 | |
| LKVKTEPVDFLDPFT | 241 | Q6DJT9 | |
| FIKTQIKVIPEFSEP | 121 | Q9H2S6 | |
| VFAPTPDFVDVEKIK | 641 | Q8WYP3 | |
| KATEVQFPVKPVVSS | 691 | Q9UKI8 | |
| LKAAVPDTVVEPALK | 236 | P09327 | |
| KQVTIKPVATAFLPV | 441 | Q9HCE3 | |
| KPVATAFLPVSAVKT | 446 | Q9HCE3 | |
| EKLVKPFVAILPTTF | 156 | Q6NUS8 | |
| QTLDEPEVPEIFTKK | 576 | Q6NZY4 | |
| TTVKVFAKPEIPVIV | 261 | P40200 | |
| ADPVTLKIETKVLQP | 2961 | Q96T58 | |
| KTQEPPVDLSKVVIE | 46 | P14649 | |
| SSEKENTQPFVVLPK | 146 | Q9BZQ8 | |
| KFFKLPVSVVNTTLP | 246 | Q658P3 | |
| FIIQPDSSIVVKPIS | 446 | Q92766 | |
| KEIFKSSSPIPRTQV | 221 | Q6FHJ7 | |
| PSVKVKEPSVQEATS | 226 | Q8IYB3 | |
| IDSEIKKTVVLPPIV | 436 | O75152 | |
| PAKKAAVAVVPLVSE | 696 | O75152 | |
| PDSRKKVPITVQSIV | 276 | Q2MV58 | |
| PPKDITISNVTKDSV | 866 | Q92752 | |
| EPIKVATLSTLLFKP | 186 | Q9Y279 | |
| ESPFATRSPKQIKIE | 746 | O43151 | |
| EVDKIPFVKADLSIP | 1031 | Q86X10 | |
| TDSEIKKTVVLPPIV | 436 | A0A1B0GTU1 | |
| IPVKESIEEPSAKIN | 1046 | O75643 | |
| EVSSQKPIEEKAVTP | 2061 | O43149 | |
| VLKVPESVAKPSQEL | 226 | Q9BY10 | |
| VGVDTPKLIVPSEFK | 746 | Q9Y6R1 | |
| TSEELKATPEIPQVK | 551 | Q8NEE8 | |
| IPVDVALPQKSSEKA | 91 | Q8N6K0 | |
| PASFDKVAIPEVKEI | 441 | Q9H4A3 | |
| ASIVDEPTFKVLLKT | 141 | O96006 | |
| FKVQTVSPREPASKV | 356 | Q9HB21 | |
| ILPITTAKVPIVKFF | 1096 | Q5VYS8 | |
| TSPNITVTLKKFPLD | 161 | P17948 | |
| TVTLKKFPLDTLIPD | 166 | P17948 | |
| PGTFKERIIKSITPE | 601 | P31645 | |
| NILPITTAKVPIVKF | 1046 | Q5TAX3 | |
| PTEKSKQVFLLSVPS | 816 | P15822 | |
| KSEKVVVEDTVPIIP | 931 | Q9UBN4 | |
| TFRKEPEKPQVEILS | 136 | Q9NUA8 | |
| IPIPTLKDFAKALET | 211 | Q9NYL9 | |
| ISTEKLTIPTEKPTI | 936 | Q9Y493 | |
| TSTQEVKIEAIPKPA | 1771 | O75096 | |
| FPTVPVKSELAVEIL | 1241 | P52179 | |
| EKCSTELFVKEPPVL | 441 | Q14896 | |
| KEKDSVPTAVTIPVA | 621 | O14974 |